nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—ALB—lung cancer	0.131	1	CbGaD
Nateglinide—ORM1—Gefitinib—lung cancer	0.0619	0.0993	CbGbCtD
Nateglinide—UGT1A9—Irinotecan—lung cancer	0.0449	0.072	CbGbCtD
Nateglinide—SLC16A1—Methotrexate—lung cancer	0.0413	0.0663	CbGbCtD
Nateglinide—ORM1—Erlotinib—lung cancer	0.0366	0.0587	CbGbCtD
Nateglinide—ALB—Gefitinib—lung cancer	0.0261	0.0418	CbGbCtD
Nateglinide—CYP3A5—Gefitinib—lung cancer	0.0209	0.0336	CbGbCtD
Nateglinide—CYP3A5—Teniposide—lung cancer	0.0203	0.0326	CbGbCtD
Nateglinide—ABCC4—Methotrexate—lung cancer	0.0199	0.0319	CbGbCtD
Nateglinide—ALB—Erlotinib—lung cancer	0.0154	0.0247	CbGbCtD
Nateglinide—CYP3A7—Paclitaxel—lung cancer	0.0151	0.0242	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0151	0.0242	CbGbCtD
Nateglinide—PTGS1—Etoposide—lung cancer	0.0149	0.0239	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0149	0.0239	CbGbCtD
Nateglinide—CYP3A7—Irinotecan—lung cancer	0.0149	0.0239	CbGbCtD
Nateglinide—CYP2C9—Gefitinib—lung cancer	0.014	0.0225	CbGbCtD
Nateglinide—ALB—Irinotecan—lung cancer	0.0139	0.0223	CbGbCtD
Nateglinide—CYP2C9—Teniposide—lung cancer	0.0136	0.0218	CbGbCtD
Nateglinide—CYP2D6—Gefitinib—lung cancer	0.0128	0.0206	CbGbCtD
Nateglinide—CYP3A5—Crizotinib—lung cancer	0.0128	0.0206	CbGbCtD
Nateglinide—CYP3A5—Erlotinib—lung cancer	0.0124	0.0199	CbGbCtD
Nateglinide—CYP3A5—Paclitaxel—lung cancer	0.0113	0.0182	CbGbCtD
Nateglinide—CYP3A5—Irinotecan—lung cancer	0.0112	0.0179	CbGbCtD
Nateglinide—CYP3A7—Docetaxel—lung cancer	0.0109	0.0175	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0109	0.0175	CbGbCtD
Nateglinide—CYP2D6—Vinorelbine—lung cancer	0.00989	0.0159	CbGbCtD
Nateglinide—CYP3A5—Etoposide—lung cancer	0.00896	0.0144	CbGbCtD
Nateglinide—CYP3A4—Topotecan—lung cancer	0.00893	0.0143	CbGbCtD
Nateglinide—SLC22A6—Methotrexate—lung cancer	0.00864	0.0139	CbGbCtD
Nateglinide—CYP3A5—Docetaxel—lung cancer	0.00819	0.0131	CbGbCtD
Nateglinide—CYP3A4—Gefitinib—lung cancer	0.00817	0.0131	CbGbCtD
Nateglinide—CYP3A4—Teniposide—lung cancer	0.00792	0.0127	CbGbCtD
Nateglinide—CYP2C9—Paclitaxel—lung cancer	0.0076	0.0122	CbGbCtD
Nateglinide—CYP2D6—Erlotinib—lung cancer	0.00759	0.0122	CbGbCtD
Nateglinide—ALB—Methotrexate—lung cancer	0.00736	0.0118	CbGbCtD
Nateglinide—CYP3A4—Vinorelbine—lung cancer	0.00629	0.0101	CbGbCtD
Nateglinide—CYP2C9—Cisplatin—lung cancer	0.00611	0.00981	CbGbCtD
Nateglinide—CYP2D6—Vinblastine—lung cancer	0.0061	0.00978	CbGbCtD
Nateglinide—CYP3A4—Crizotinib—lung cancer	0.005	0.00803	CbGbCtD
Nateglinide—CYP3A4—Erlotinib—lung cancer	0.00483	0.00775	CbGbCtD
Nateglinide—CYP3A4—Paclitaxel—lung cancer	0.00442	0.00709	CbGbCtD
Nateglinide—CYP3A4—Irinotecan—lung cancer	0.00436	0.00699	CbGbCtD
Nateglinide—CYP3A4—Vinblastine—lung cancer	0.00388	0.00622	CbGbCtD
Nateglinide—CYP2D6—Doxorubicin—lung cancer	0.00375	0.00601	CbGbCtD
Nateglinide—CYP3A4—Etoposide—lung cancer	0.00349	0.0056	CbGbCtD
Nateglinide—CYP3A4—Docetaxel—lung cancer	0.0032	0.00513	CbGbCtD
Nateglinide—CYP3A4—Doxorubicin—lung cancer	0.00238	0.00382	CbGbCtD
Nateglinide—KCNJ11—mammary gland—lung cancer	0.00146	0.08	CbGeAlD
Nateglinide—PPARG—Irinotecan—Topotecan—lung cancer	0.00137	0.33	CbGdCrCtD
Nateglinide—ABCC8—mammary gland—lung cancer	0.00135	0.0737	CbGeAlD
Nateglinide—PPARG—Topotecan—Irinotecan—lung cancer	0.00114	0.274	CbGdCrCtD
Nateglinide—PPARG—Etoposide—Teniposide—lung cancer	0.00113	0.272	CbGdCrCtD
Nateglinide—PPARG—mammary gland—lung cancer	0.00103	0.0562	CbGeAlD
Nateglinide—ALB—mammary gland—lung cancer	0.000965	0.0527	CbGeAlD
Nateglinide—SLC15A2—mammary gland—lung cancer	0.000806	0.044	CbGeAlD
Nateglinide—SLC15A1—epithelium—lung cancer	0.000718	0.0392	CbGeAlD
Nateglinide—PPARG—respiratory system—lung cancer	0.000686	0.0375	CbGeAlD
Nateglinide—SLC16A1—epithelium—lung cancer	0.000683	0.0373	CbGeAlD
Nateglinide—CYP2C9—mammary gland—lung cancer	0.000603	0.0329	CbGeAlD
Nateglinide—PPARG—epithelium—lung cancer	0.000573	0.0313	CbGeAlD
Nateglinide—SLC16A1—cardiac atrium—lung cancer	0.000567	0.031	CbGeAlD
Nateglinide—SLC15A2—respiratory system—lung cancer	0.000537	0.0293	CbGeAlD
Nateglinide—PPARG—Teniposide—Etoposide—lung cancer	0.000513	0.124	CbGdCrCtD
Nateglinide—ABCC4—bronchus—lung cancer	0.000512	0.028	CbGeAlD
Nateglinide—SLC15A2—bronchus—lung cancer	0.000442	0.0241	CbGeAlD
Nateglinide—SLC16A1—lung—lung cancer	0.000434	0.0237	CbGeAlD
Nateglinide—ORM1—bone marrow—lung cancer	0.00043	0.0235	CbGeAlD
Nateglinide—CYP3A5—respiratory system—lung cancer	0.000408	0.0223	CbGeAlD
Nateglinide—PPARG—bone marrow—lung cancer	0.000402	0.022	CbGeAlD
Nateglinide—SLC15A2—trachea—lung cancer	0.000397	0.0217	CbGeAlD
Nateglinide—ORM1—lung—lung cancer	0.000389	0.0213	CbGeAlD
Nateglinide—Sweating—Gemcitabine—lung cancer	0.000378	0.0036	CcSEcCtD
Nateglinide—Hepatobiliary disease—Gemcitabine—lung cancer	0.000373	0.00355	CcSEcCtD
Nateglinide—Back pain—Vinorelbine—lung cancer	0.000371	0.00353	CcSEcCtD
Nateglinide—Influenza—Paclitaxel—lung cancer	0.00037	0.00353	CcSEcCtD
Nateglinide—Sweating increased—Etoposide—lung cancer	0.000368	0.0035	CcSEcCtD
Nateglinide—PTGS1—respiratory system—lung cancer	0.000367	0.02	CbGeAlD
Nateglinide—ABCC4—bone marrow—lung cancer	0.000365	0.0199	CbGeAlD
Nateglinide—PPARG—lung—lung cancer	0.000364	0.0199	CbGeAlD
Nateglinide—Hypersensitivity—Teniposide—lung cancer	0.000364	0.00346	CcSEcCtD
Nateglinide—Nausea—Pemetrexed—lung cancer	0.000362	0.00345	CcSEcCtD
Nateglinide—Sweating increased—Paclitaxel—lung cancer	0.000361	0.00343	CcSEcCtD
Nateglinide—Neuropathy peripheral—Cisplatin—lung cancer	0.00036	0.00343	CcSEcCtD
Nateglinide—Nausea—Gefitinib—lung cancer	0.00036	0.00343	CcSEcCtD
Nateglinide—Bronchitis—Paclitaxel—lung cancer	0.000356	0.00339	CcSEcCtD
Nateglinide—Bortezomib—CYP1A1—lung cancer	0.000355	0.316	CrCbGaD
Nateglinide—Asthenia—Teniposide—lung cancer	0.000354	0.00337	CcSEcCtD
Nateglinide—KCNJ11—lymph node—lung cancer	0.000354	0.0194	CbGeAlD
Nateglinide—Hyperhidrosis—Topotecan—lung cancer	0.000354	0.00337	CcSEcCtD
Nateglinide—Pruritus—Teniposide—lung cancer	0.000349	0.00333	CcSEcCtD
Nateglinide—Oedema peripheral—Gemcitabine—lung cancer	0.000349	0.00332	CcSEcCtD
Nateglinide—Hepatobiliary disease—Cisplatin—lung cancer	0.000348	0.00331	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Paclitaxel—lung cancer	0.000344	0.00328	CcSEcCtD
Nateglinide—Arthropathy—Doxorubicin—lung cancer	0.000343	0.00327	CcSEcCtD
Nateglinide—Palpitations—Vinorelbine—lung cancer	0.000339	0.00323	CcSEcCtD
Nateglinide—Diarrhoea—Teniposide—lung cancer	0.000338	0.00322	CcSEcCtD
Nateglinide—Cough—Vinorelbine—lung cancer	0.000335	0.00319	CcSEcCtD
Nateglinide—Erythema multiforme—Gemcitabine—lung cancer	0.000335	0.00319	CcSEcCtD
Nateglinide—ABCC4—lung—lung cancer	0.000331	0.0181	CbGeAlD
Nateglinide—Neuropathy peripheral—Etoposide—lung cancer	0.00033	0.00314	CcSEcCtD
Nateglinide—Immune system disorder—Irinotecan—lung cancer	0.000328	0.00313	CcSEcCtD
Nateglinide—Jaundice—Etoposide—lung cancer	0.000328	0.00313	CcSEcCtD
Nateglinide—Urine output increased—Methotrexate—lung cancer	0.000326	0.0031	CcSEcCtD
Nateglinide—Neuropathy peripheral—Paclitaxel—lung cancer	0.000324	0.00308	CcSEcCtD
Nateglinide—Dyspepsia—Topotecan—lung cancer	0.000322	0.00307	CcSEcCtD
Nateglinide—Immune system disorder—Gemcitabine—lung cancer	0.00032	0.00304	CcSEcCtD
Nateglinide—Dyspepsia—Erlotinib—lung cancer	0.000319	0.00304	CcSEcCtD
Nateglinide—Hepatobiliary disease—Etoposide—lung cancer	0.000319	0.00303	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Topotecan—lung cancer	0.000316	0.00301	CcSEcCtD
Nateglinide—Fatigue—Topotecan—lung cancer	0.000316	0.003	CcSEcCtD
Nateglinide—Vomiting—Teniposide—lung cancer	0.000314	0.00299	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Erlotinib—lung cancer	0.000313	0.00298	CcSEcCtD
Nateglinide—Hepatobiliary disease—Paclitaxel—lung cancer	0.000312	0.00297	CcSEcCtD
Nateglinide—Fatigue—Erlotinib—lung cancer	0.000312	0.00297	CcSEcCtD
Nateglinide—Rash—Teniposide—lung cancer	0.000311	0.00296	CcSEcCtD
Nateglinide—Dermatitis—Teniposide—lung cancer	0.000311	0.00296	CcSEcCtD
Nateglinide—Gastrointestinal pain—Vinblastine—lung cancer	0.000308	0.00293	CcSEcCtD
Nateglinide—PTGS1—epithelium—lung cancer	0.000306	0.0167	CbGeAlD
Nateglinide—Back pain—Irinotecan—lung cancer	0.000306	0.00291	CcSEcCtD
Nateglinide—Gastrointestinal pain—Topotecan—lung cancer	0.000299	0.00285	CcSEcCtD
Nateglinide—Back pain—Gemcitabine—lung cancer	0.000298	0.00284	CcSEcCtD
Nateglinide—Polyuria—Methotrexate—lung cancer	0.000298	0.00284	CcSEcCtD
Nateglinide—Immune system disorder—Cisplatin—lung cancer	0.000298	0.00284	CcSEcCtD
Nateglinide—Abdominal pain—Vinblastine—lung cancer	0.000298	0.00284	CcSEcCtD
Nateglinide—SLC16A1—lymph node—lung cancer	0.000297	0.0162	CbGeAlD
Nateglinide—Gastrointestinal pain—Erlotinib—lung cancer	0.000296	0.00282	CcSEcCtD
Nateglinide—Nausea—Teniposide—lung cancer	0.000293	0.00279	CcSEcCtD
Nateglinide—Oedema peripheral—Paclitaxel—lung cancer	0.000292	0.00278	CcSEcCtD
Nateglinide—Urticaria—Topotecan—lung cancer	0.000291	0.00277	CcSEcCtD
Nateglinide—Abdominal pain—Topotecan—lung cancer	0.000289	0.00275	CcSEcCtD
Nateglinide—Malnutrition—Cisplatin—lung cancer	0.000287	0.00274	CcSEcCtD
Nateglinide—Abdominal pain—Erlotinib—lung cancer	0.000286	0.00273	CcSEcCtD
Nateglinide—Erythema multiforme—Etoposide—lung cancer	0.000286	0.00272	CcSEcCtD
Nateglinide—SLC15A2—lung—lung cancer	0.000285	0.0156	CbGeAlD
Nateglinide—Erythema multiforme—Paclitaxel—lung cancer	0.00028	0.00267	CcSEcCtD
Nateglinide—Hypersensitivity—Vinblastine—lung cancer	0.000278	0.00264	CcSEcCtD
Nateglinide—Cough—Irinotecan—lung cancer	0.000276	0.00263	CcSEcCtD
Nateglinide—Neuropathy peripheral—Docetaxel—lung cancer	0.000274	0.00261	CcSEcCtD
Nateglinide—Immune system disorder—Etoposide—lung cancer	0.000273	0.0026	CcSEcCtD
Nateglinide—Jaundice—Docetaxel—lung cancer	0.000273	0.0026	CcSEcCtD
Nateglinide—PTGS1—trachea—lung cancer	0.000271	0.0148	CbGeAlD
Nateglinide—Asthenia—Vinblastine—lung cancer	0.00027	0.00257	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Vinorelbine—lung cancer	0.00027	0.00257	CcSEcCtD
Nateglinide—Fatigue—Vinorelbine—lung cancer	0.00027	0.00257	CcSEcCtD
Nateglinide—Hypersensitivity—Topotecan—lung cancer	0.00027	0.00257	CcSEcCtD
Nateglinide—Tremor—Cisplatin—lung cancer	0.000269	0.00256	CcSEcCtD
Nateglinide—Cough—Gemcitabine—lung cancer	0.000269	0.00256	CcSEcCtD
Nateglinide—Immune system disorder—Paclitaxel—lung cancer	0.000268	0.00255	CcSEcCtD
Nateglinide—ORM1—lymph node—lung cancer	0.000266	0.0146	CbGeAlD
Nateglinide—Hepatobiliary disease—Docetaxel—lung cancer	0.000265	0.00252	CcSEcCtD
Nateglinide—Asthenia—Topotecan—lung cancer	0.000263	0.0025	CcSEcCtD
Nateglinide—Osteoarthritis—Methotrexate—lung cancer	0.000262	0.00249	CcSEcCtD
Nateglinide—Asthenia—Erlotinib—lung cancer	0.00026	0.00247	CcSEcCtD
Nateglinide—Pruritus—Topotecan—lung cancer	0.000259	0.00247	CcSEcCtD
Nateglinide—Malnutrition—Paclitaxel—lung cancer	0.000258	0.00246	CcSEcCtD
Nateglinide—Diarrhoea—Vinblastine—lung cancer	0.000258	0.00245	CcSEcCtD
Nateglinide—Pruritus—Erlotinib—lung cancer	0.000256	0.00244	CcSEcCtD
Nateglinide—Gastrointestinal pain—Vinorelbine—lung cancer	0.000256	0.00244	CcSEcCtD
Nateglinide—Back pain—Etoposide—lung cancer	0.000255	0.00242	CcSEcCtD
Nateglinide—PTGS1—cardiac atrium—lung cancer	0.000254	0.0139	CbGeAlD
Nateglinide—Diarrhoea—Topotecan—lung cancer	0.00025	0.00238	CcSEcCtD
Nateglinide—Hyperhidrosis—Irinotecan—lung cancer	0.00025	0.00238	CcSEcCtD
Nateglinide—Back pain—Paclitaxel—lung cancer	0.00025	0.00238	CcSEcCtD
Nateglinide—Dizziness—Vinblastine—lung cancer	0.000249	0.00237	CcSEcCtD
Nateglinide—PPARG—lymph node—lung cancer	0.000249	0.0136	CbGeAlD
Nateglinide—Urticaria—Vinorelbine—lung cancer	0.000249	0.00237	CcSEcCtD
Nateglinide—Diarrhoea—Erlotinib—lung cancer	0.000248	0.00236	CcSEcCtD
Nateglinide—Abdominal pain—Vinorelbine—lung cancer	0.000248	0.00236	CcSEcCtD
Nateglinide—Oedema peripheral—Docetaxel—lung cancer	0.000248	0.00236	CcSEcCtD
Nateglinide—Hyperhidrosis—Gemcitabine—lung cancer	0.000243	0.00232	CcSEcCtD
Nateglinide—Dizziness—Topotecan—lung cancer	0.000242	0.0023	CcSEcCtD
Nateglinide—Amphetamine—CYP2A6—lung cancer	0.000242	0.215	CrCbGaD
Nateglinide—Tremor—Paclitaxel—lung cancer	0.000242	0.0023	CcSEcCtD
Nateglinide—Increased appetite—Doxorubicin—lung cancer	0.000241	0.0023	CcSEcCtD
Nateglinide—Vomiting—Vinblastine—lung cancer	0.00024	0.00228	CcSEcCtD
Nateglinide—Dizziness—Erlotinib—lung cancer	0.00024	0.00228	CcSEcCtD
Nateglinide—Erythema multiforme—Docetaxel—lung cancer	0.000238	0.00226	CcSEcCtD
Nateglinide—ALB—lymph node—lung cancer	0.000234	0.0128	CbGeAlD
Nateglinide—Vomiting—Topotecan—lung cancer	0.000233	0.00222	CcSEcCtD
Nateglinide—Hypoglycaemia—Doxorubicin—lung cancer	0.000232	0.00221	CcSEcCtD
Nateglinide—Rash—Topotecan—lung cancer	0.000231	0.0022	CcSEcCtD
Nateglinide—Hypersensitivity—Vinorelbine—lung cancer	0.000231	0.0022	CcSEcCtD
Nateglinide—Dermatitis—Topotecan—lung cancer	0.000231	0.0022	CcSEcCtD
Nateglinide—Vomiting—Erlotinib—lung cancer	0.00023	0.00219	CcSEcCtD
Nateglinide—Cough—Etoposide—lung cancer	0.00023	0.00219	CcSEcCtD
Nateglinide—Rash—Erlotinib—lung cancer	0.000228	0.00217	CcSEcCtD
Nateglinide—Dermatitis—Erlotinib—lung cancer	0.000228	0.00217	CcSEcCtD
Nateglinide—Palpitations—Paclitaxel—lung cancer	0.000228	0.00217	CcSEcCtD
Nateglinide—Dyspepsia—Irinotecan—lung cancer	0.000227	0.00216	CcSEcCtD
Nateglinide—Immune system disorder—Docetaxel—lung cancer	0.000227	0.00216	CcSEcCtD
Nateglinide—Osteoarthritis—Doxorubicin—lung cancer	0.000227	0.00216	CcSEcCtD
Nateglinide—Hyperhidrosis—Cisplatin—lung cancer	0.000227	0.00216	CcSEcCtD
Nateglinide—ABCC4—lymph node—lung cancer	0.000226	0.0124	CbGeAlD
Nateglinide—Cough—Paclitaxel—lung cancer	0.000225	0.00214	CcSEcCtD
Nateglinide—Asthenia—Vinorelbine—lung cancer	0.000225	0.00214	CcSEcCtD
Nateglinide—Nausea—Vinblastine—lung cancer	0.000224	0.00213	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Irinotecan—lung cancer	0.000223	0.00212	CcSEcCtD
Nateglinide—Fatigue—Irinotecan—lung cancer	0.000223	0.00212	CcSEcCtD
Nateglinide—Pruritus—Vinorelbine—lung cancer	0.000222	0.00211	CcSEcCtD
Nateglinide—Malnutrition—Docetaxel—lung cancer	0.000219	0.00208	CcSEcCtD
Nateglinide—Nausea—Topotecan—lung cancer	0.000217	0.00207	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000217	0.00207	CcSEcCtD
Nateglinide—Fatigue—Gemcitabine—lung cancer	0.000217	0.00206	CcSEcCtD
Nateglinide—CYP3A5—lung—lung cancer	0.000217	0.0118	CbGeAlD
Nateglinide—Nausea—Erlotinib—lung cancer	0.000215	0.00205	CcSEcCtD
Nateglinide—Diarrhoea—Vinorelbine—lung cancer	0.000214	0.00204	CcSEcCtD
Nateglinide—Back pain—Docetaxel—lung cancer	0.000212	0.00201	CcSEcCtD
Nateglinide—Gastrointestinal pain—Irinotecan—lung cancer	0.000211	0.00201	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Methotrexate—lung cancer	0.00021	0.002	CcSEcCtD
Nateglinide—Hyperhidrosis—Etoposide—lung cancer	0.000208	0.00198	CcSEcCtD
Nateglinide—Dizziness—Vinorelbine—lung cancer	0.000207	0.00197	CcSEcCtD
Nateglinide—Abdominal pain—Irinotecan—lung cancer	0.000204	0.00194	CcSEcCtD
Nateglinide—Hyperhidrosis—Paclitaxel—lung cancer	0.000204	0.00194	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Cisplatin—lung cancer	0.000202	0.00193	CcSEcCtD
Nateglinide—Vomiting—Vinorelbine—lung cancer	0.000199	0.0019	CcSEcCtD
Nateglinide—Rash—Vinorelbine—lung cancer	0.000197	0.00188	CcSEcCtD
Nateglinide—Dermatitis—Vinorelbine—lung cancer	0.000197	0.00188	CcSEcCtD
Nateglinide—Influenza—Doxorubicin—lung cancer	0.000196	0.00187	CcSEcCtD
Nateglinide—SLC15A2—lymph node—lung cancer	0.000195	0.0107	CbGeAlD
Nateglinide—PTGS1—lung—lung cancer	0.000195	0.0106	CbGeAlD
Nateglinide—Sweating—Methotrexate—lung cancer	0.000193	0.00184	CcSEcCtD
Nateglinide—Lisinopril—ABCB1—lung cancer	0.000193	0.172	CrCbGaD
Nateglinide—Cilazapril—ABCB1—lung cancer	0.000193	0.172	CrCbGaD
Nateglinide—Palpitations—Docetaxel—lung cancer	0.000193	0.00184	CcSEcCtD
Nateglinide—Cough—Docetaxel—lung cancer	0.000191	0.00182	CcSEcCtD
Nateglinide—Hepatobiliary disease—Methotrexate—lung cancer	0.000191	0.00182	CcSEcCtD
Nateglinide—Hypersensitivity—Irinotecan—lung cancer	0.00019	0.00181	CcSEcCtD
Nateglinide—Bronchitis—Doxorubicin—lung cancer	0.000188	0.00179	CcSEcCtD
Nateglinide—Nausea—Vinorelbine—lung cancer	0.000186	0.00177	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Etoposide—lung cancer	0.000185	0.00177	CcSEcCtD
Nateglinide—Dyspepsia—Paclitaxel—lung cancer	0.000185	0.00177	CcSEcCtD
Nateglinide—Asthenia—Irinotecan—lung cancer	0.000185	0.00176	CcSEcCtD
Nateglinide—Fatigue—Etoposide—lung cancer	0.000185	0.00176	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000182	0.00173	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000182	0.00173	CcSEcCtD
Nateglinide—Fatigue—Paclitaxel—lung cancer	0.000182	0.00173	CcSEcCtD
Nateglinide—Asthenia—Gemcitabine—lung cancer	0.000181	0.00172	CcSEcCtD
Nateglinide—Pruritus—Gemcitabine—lung cancer	0.000178	0.00169	CcSEcCtD
Nateglinide—Diarrhoea—Irinotecan—lung cancer	0.000177	0.00168	CcSEcCtD
Nateglinide—Gastrointestinal pain—Etoposide—lung cancer	0.000176	0.00167	CcSEcCtD
Nateglinide—Hypersensitivity—Cisplatin—lung cancer	0.000173	0.00164	CcSEcCtD
Nateglinide—Gastrointestinal pain—Paclitaxel—lung cancer	0.000172	0.00164	CcSEcCtD
Nateglinide—Diarrhoea—Gemcitabine—lung cancer	0.000172	0.00164	CcSEcCtD
Nateglinide—Erythema multiforme—Methotrexate—lung cancer	0.000171	0.00163	CcSEcCtD
Nateglinide—Neuropathy peripheral—Doxorubicin—lung cancer	0.000171	0.00163	CcSEcCtD
Nateglinide—Dizziness—Irinotecan—lung cancer	0.000171	0.00163	CcSEcCtD
Nateglinide—Urticaria—Etoposide—lung cancer	0.000171	0.00162	CcSEcCtD
Nateglinide—Jaundice—Doxorubicin—lung cancer	0.00017	0.00162	CcSEcCtD
Nateglinide—Abdominal pain—Etoposide—lung cancer	0.00017	0.00162	CcSEcCtD
Nateglinide—Asthenia—Cisplatin—lung cancer	0.000168	0.0016	CcSEcCtD
Nateglinide—Sweating—Doxorubicin—lung cancer	0.000167	0.00159	CcSEcCtD
Nateglinide—Urticaria—Paclitaxel—lung cancer	0.000167	0.00159	CcSEcCtD
Nateglinide—Abdominal pain—Paclitaxel—lung cancer	0.000167	0.00159	CcSEcCtD
Nateglinide—Hepatobiliary disease—Doxorubicin—lung cancer	0.000165	0.00157	CcSEcCtD
Nateglinide—Vomiting—Irinotecan—lung cancer	0.000164	0.00156	CcSEcCtD
Nateglinide—Immune system disorder—Methotrexate—lung cancer	0.000164	0.00156	CcSEcCtD
Nateglinide—Rash—Irinotecan—lung cancer	0.000163	0.00155	CcSEcCtD
Nateglinide—Dermatitis—Irinotecan—lung cancer	0.000163	0.00155	CcSEcCtD
Nateglinide—Diarrhoea—Cisplatin—lung cancer	0.00016	0.00153	CcSEcCtD
Nateglinide—Vomiting—Gemcitabine—lung cancer	0.00016	0.00152	CcSEcCtD
Nateglinide—Rash—Gemcitabine—lung cancer	0.000159	0.00151	CcSEcCtD
Nateglinide—Dermatitis—Gemcitabine—lung cancer	0.000158	0.00151	CcSEcCtD
Nateglinide—Hypersensitivity—Etoposide—lung cancer	0.000158	0.00151	CcSEcCtD
Nateglinide—Malnutrition—Methotrexate—lung cancer	0.000158	0.0015	CcSEcCtD
Nateglinide—Dyspepsia—Docetaxel—lung cancer	0.000157	0.0015	CcSEcCtD
Nateglinide—Hypersensitivity—Paclitaxel—lung cancer	0.000155	0.00148	CcSEcCtD
Nateglinide—Oedema peripheral—Doxorubicin—lung cancer	0.000155	0.00147	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Docetaxel—lung cancer	0.000154	0.00147	CcSEcCtD
Nateglinide—Asthenia—Etoposide—lung cancer	0.000154	0.00147	CcSEcCtD
Nateglinide—Fatigue—Docetaxel—lung cancer	0.000154	0.00147	CcSEcCtD
Nateglinide—Nausea—Irinotecan—lung cancer	0.000153	0.00146	CcSEcCtD
Nateglinide—Back pain—Methotrexate—lung cancer	0.000153	0.00145	CcSEcCtD
Nateglinide—Pruritus—Etoposide—lung cancer	0.000152	0.00145	CcSEcCtD
Nateglinide—Asthenia—Paclitaxel—lung cancer	0.000151	0.00144	CcSEcCtD
Nateglinide—Nausea—Gemcitabine—lung cancer	0.000149	0.00142	CcSEcCtD
Nateglinide—Vomiting—Cisplatin—lung cancer	0.000149	0.00142	CcSEcCtD
Nateglinide—Pruritus—Paclitaxel—lung cancer	0.000149	0.00142	CcSEcCtD
Nateglinide—Erythema multiforme—Doxorubicin—lung cancer	0.000148	0.00141	CcSEcCtD
Nateglinide—Rash—Cisplatin—lung cancer	0.000148	0.00141	CcSEcCtD
Nateglinide—Dermatitis—Cisplatin—lung cancer	0.000148	0.00141	CcSEcCtD
Nateglinide—Diarrhoea—Etoposide—lung cancer	0.000147	0.0014	CcSEcCtD
Nateglinide—Gastrointestinal pain—Docetaxel—lung cancer	0.000146	0.00139	CcSEcCtD
Nateglinide—Diarrhoea—Paclitaxel—lung cancer	0.000144	0.00137	CcSEcCtD
Nateglinide—Dizziness—Etoposide—lung cancer	0.000142	0.00135	CcSEcCtD
Nateglinide—Enalapril—ABCB1—lung cancer	0.000142	0.126	CrCbGaD
Nateglinide—Immune system disorder—Doxorubicin—lung cancer	0.000142	0.00135	CcSEcCtD
Nateglinide—Abdominal pain—Docetaxel—lung cancer	0.000141	0.00134	CcSEcCtD
Nateglinide—Dizziness—Paclitaxel—lung cancer	0.000139	0.00133	CcSEcCtD
Nateglinide—Nausea—Cisplatin—lung cancer	0.000139	0.00133	CcSEcCtD
Nateglinide—Cough—Methotrexate—lung cancer	0.000138	0.00131	CcSEcCtD
Nateglinide—Vomiting—Etoposide—lung cancer	0.000137	0.0013	CcSEcCtD
Nateglinide—Malnutrition—Doxorubicin—lung cancer	0.000137	0.0013	CcSEcCtD
Nateglinide—Rash—Etoposide—lung cancer	0.000135	0.00129	CcSEcCtD
Nateglinide—Dermatitis—Etoposide—lung cancer	0.000135	0.00129	CcSEcCtD
Nateglinide—Vomiting—Paclitaxel—lung cancer	0.000134	0.00127	CcSEcCtD
Nateglinide—PTGS1—lymph node—lung cancer	0.000133	0.00727	CbGeAlD
Nateglinide—Rash—Paclitaxel—lung cancer	0.000133	0.00126	CcSEcCtD
Nateglinide—Dermatitis—Paclitaxel—lung cancer	0.000133	0.00126	CcSEcCtD
Nateglinide—Back pain—Doxorubicin—lung cancer	0.000132	0.00126	CcSEcCtD
Nateglinide—Hypersensitivity—Docetaxel—lung cancer	0.000132	0.00125	CcSEcCtD
Nateglinide—Asthenia—Docetaxel—lung cancer	0.000128	0.00122	CcSEcCtD
Nateglinide—Nausea—Etoposide—lung cancer	0.000128	0.00121	CcSEcCtD
Nateglinide—Pruritus—Docetaxel—lung cancer	0.000126	0.0012	CcSEcCtD
Nateglinide—Nausea—Paclitaxel—lung cancer	0.000125	0.00119	CcSEcCtD
Nateglinide—Hyperhidrosis—Methotrexate—lung cancer	0.000124	0.00118	CcSEcCtD
Nateglinide—Diarrhoea—Docetaxel—lung cancer	0.000122	0.00116	CcSEcCtD
Nateglinide—Palpitations—Doxorubicin—lung cancer	0.000121	0.00115	CcSEcCtD
Nateglinide—Cough—Doxorubicin—lung cancer	0.000119	0.00113	CcSEcCtD
Nateglinide—Dizziness—Docetaxel—lung cancer	0.000118	0.00112	CcSEcCtD
Nateglinide—Vomiting—Docetaxel—lung cancer	0.000114	0.00108	CcSEcCtD
Nateglinide—Dyspepsia—Methotrexate—lung cancer	0.000113	0.00108	CcSEcCtD
Nateglinide—Rash—Docetaxel—lung cancer	0.000113	0.00107	CcSEcCtD
Nateglinide—Dermatitis—Docetaxel—lung cancer	0.000112	0.00107	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Methotrexate—lung cancer	0.000111	0.00106	CcSEcCtD
Nateglinide—Fatigue—Methotrexate—lung cancer	0.000111	0.00106	CcSEcCtD
Nateglinide—Hyperhidrosis—Doxorubicin—lung cancer	0.000108	0.00103	CcSEcCtD
Nateglinide—Nausea—Docetaxel—lung cancer	0.000106	0.00101	CcSEcCtD
Nateglinide—Gastrointestinal pain—Methotrexate—lung cancer	0.000105	0.001	CcSEcCtD
Nateglinide—Urticaria—Methotrexate—lung cancer	0.000102	0.000973	CcSEcCtD
Nateglinide—Abdominal pain—Methotrexate—lung cancer	0.000102	0.000968	CcSEcCtD
Nateglinide—Dyspepsia—Doxorubicin—lung cancer	9.81e-05	0.000934	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Doxorubicin—lung cancer	9.62e-05	0.000916	CcSEcCtD
Nateglinide—Fatigue—Doxorubicin—lung cancer	9.61e-05	0.000915	CcSEcCtD
Nateglinide—Hypersensitivity—Methotrexate—lung cancer	9.48e-05	0.000903	CcSEcCtD
Nateglinide—Asthenia—Methotrexate—lung cancer	9.23e-05	0.000879	CcSEcCtD
Nateglinide—Gastrointestinal pain—Doxorubicin—lung cancer	9.11e-05	0.000867	CcSEcCtD
Nateglinide—Pruritus—Methotrexate—lung cancer	9.1e-05	0.000867	CcSEcCtD
Nateglinide—Urticaria—Doxorubicin—lung cancer	8.85e-05	0.000843	CcSEcCtD
Nateglinide—Abdominal pain—Doxorubicin—lung cancer	8.81e-05	0.000839	CcSEcCtD
Nateglinide—Diarrhoea—Methotrexate—lung cancer	8.8e-05	0.000838	CcSEcCtD
Nateglinide—Dizziness—Methotrexate—lung cancer	8.51e-05	0.00081	CcSEcCtD
Nateglinide—Hypersensitivity—Doxorubicin—lung cancer	8.21e-05	0.000782	CcSEcCtD
Nateglinide—Vomiting—Methotrexate—lung cancer	8.18e-05	0.000779	CcSEcCtD
Nateglinide—Rash—Methotrexate—lung cancer	8.11e-05	0.000772	CcSEcCtD
Nateglinide—Dermatitis—Methotrexate—lung cancer	8.11e-05	0.000772	CcSEcCtD
Nateglinide—Asthenia—Doxorubicin—lung cancer	7.99e-05	0.000761	CcSEcCtD
Nateglinide—Pruritus—Doxorubicin—lung cancer	7.88e-05	0.00075	CcSEcCtD
Nateglinide—Nausea—Methotrexate—lung cancer	7.64e-05	0.000728	CcSEcCtD
Nateglinide—Diarrhoea—Doxorubicin—lung cancer	7.62e-05	0.000726	CcSEcCtD
Nateglinide—Dizziness—Doxorubicin—lung cancer	7.37e-05	0.000701	CcSEcCtD
Nateglinide—Vomiting—Doxorubicin—lung cancer	7.08e-05	0.000674	CcSEcCtD
Nateglinide—Rash—Doxorubicin—lung cancer	7.03e-05	0.000669	CcSEcCtD
Nateglinide—Dermatitis—Doxorubicin—lung cancer	7.02e-05	0.000668	CcSEcCtD
Nateglinide—Nausea—Doxorubicin—lung cancer	6.62e-05	0.00063	CcSEcCtD
Nateglinide—CYP3A4—Metabolism—PGAM1—lung cancer	7.19e-06	6.15e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ERCC2—lung cancer	7.19e-06	6.15e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GNG11—lung cancer	7.15e-06	6.12e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	7.11e-06	6.09e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.08e-06	6.06e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTEN—lung cancer	7.04e-06	6.02e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP1A1—lung cancer	7.02e-06	6.01e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ENO1—lung cancer	7e-06	5.99e-05	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	7e-06	5.98e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.98e-06	5.97e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ERCC2—lung cancer	6.97e-06	5.96e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTEN—lung cancer	6.94e-06	5.93e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—EP300—lung cancer	6.92e-06	5.92e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CD—lung cancer	6.9e-06	5.91e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALDOA—lung cancer	6.87e-06	5.87e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP2A7—lung cancer	6.86e-06	5.87e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—RAF1—lung cancer	6.84e-06	5.85e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ALB—lung cancer	6.82e-06	5.83e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALDOA—lung cancer	6.81e-06	5.82e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CG—lung cancer	6.75e-06	5.77e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SDC4—lung cancer	6.72e-06	5.75e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—EP300—lung cancer	6.71e-06	5.74e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CB—lung cancer	6.68e-06	5.71e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NCOA3—lung cancer	6.67e-06	5.7e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—EP300—lung cancer	6.61e-06	5.66e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NCOA3—lung cancer	6.61e-06	5.65e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—STK11—lung cancer	6.5e-06	5.56e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	6.49e-06	5.56e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ADCY1—lung cancer	6.49e-06	5.55e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ABCG2—lung cancer	6.49e-06	5.55e-05	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	6.45e-06	5.52e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ADCY1—lung cancer	6.43e-06	5.5e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ABCG2—lung cancer	6.43e-06	5.5e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—POMC—lung cancer	6.42e-06	5.5e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HPGDS—lung cancer	6.36e-06	5.44e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ENO2—lung cancer	6.36e-06	5.44e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPP2R1B—lung cancer	6.32e-06	5.41e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HPGDS—lung cancer	6.31e-06	5.39e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ENO2—lung cancer	6.31e-06	5.39e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP2E1—lung cancer	6.28e-06	5.37e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPP2R1B—lung cancer	6.27e-06	5.36e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CREBBP—lung cancer	6.26e-06	5.35e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—APOA1—lung cancer	6.22e-06	5.32e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NQO1—lung cancer	6.21e-06	5.31e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.18e-06	5.29e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTT1—lung cancer	6.17e-06	5.28e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IL2—lung cancer	6.13e-06	5.25e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—RRM1—lung cancer	6.12e-06	5.23e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTA3—lung cancer	6.12e-06	5.23e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTT1—lung cancer	6.12e-06	5.23e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP2A6—lung cancer	6.1e-06	5.22e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GCLC—lung cancer	6.1e-06	5.22e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.08e-06	5.2e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP2A6—lung cancer	6.05e-06	5.17e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GCLC—lung cancer	6.05e-06	5.17e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—APOA1—lung cancer	6.03e-06	5.16e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.02e-06	5.15e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.02e-06	5.15e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CB—lung cancer	6.02e-06	5.15e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTP1—lung cancer	6.01e-06	5.14e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTGS2—lung cancer	5.96e-06	5.1e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CD—lung cancer	5.93e-06	5.08e-05	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	5.92e-06	5.07e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ALB—lung cancer	5.86e-06	5.01e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CAT—lung cancer	5.85e-06	5.01e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ENO1—lung cancer	5.78e-06	4.94e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.77e-06	4.94e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—B4GALT5—lung cancer	5.75e-06	4.92e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ENO1—lung cancer	5.73e-06	4.9e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MAPK3—lung cancer	5.71e-06	4.89e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.71e-06	4.88e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ABCB1—lung cancer	5.69e-06	4.87e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CG—lung cancer	5.68e-06	4.86e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.64e-06	4.82e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—STK11—lung cancer	5.6e-06	4.79e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTA4—lung cancer	5.6e-06	4.79e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TYMS—lung cancer	5.59e-06	4.78e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MYC—lung cancer	5.56e-06	4.75e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTM1—lung cancer	5.53e-06	4.73e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—EP300—lung cancer	5.5e-06	4.71e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CG—lung cancer	5.5e-06	4.71e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTA2—lung cancer	5.45e-06	4.66e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—POMC—lung cancer	5.4e-06	4.62e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SRC—lung cancer	5.35e-06	4.58e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CREBBP—lung cancer	5.26e-06	4.5e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTA1—lung cancer	5.26e-06	4.5e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.25e-06	4.49e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP1A1—lung cancer	5.24e-06	4.48e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—POMC—lung cancer	5.24e-06	4.48e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—lung cancer	5.21e-06	4.46e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ABCC3—lung cancer	5.2e-06	4.45e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTEN—lung cancer	5.2e-06	4.45e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ERCC2—lung cancer	5.2e-06	4.44e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP2E1—lung cancer	5.18e-06	4.44e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTP1—lung cancer	5.18e-06	4.43e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CB—lung cancer	5.17e-06	4.42e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—NRAS—lung cancer	5.15e-06	4.4e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP2E1—lung cancer	5.14e-06	4.4e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NQO1—lung cancer	5.13e-06	4.39e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—lung cancer	5.12e-06	4.38e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CA—lung cancer	5.12e-06	4.38e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CREBBP—lung cancer	5.1e-06	4.36e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NQO1—lung cancer	5.08e-06	4.35e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CAT—lung cancer	5.04e-06	4.31e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKR1C1—lung cancer	5.04e-06	4.31e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.01e-06	4.29e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CD—lung cancer	4.99e-06	4.27e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.98e-06	4.26e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CA—lung cancer	4.96e-06	4.25e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—EP300—lung cancer	4.96e-06	4.24e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.93e-06	4.22e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—MAPK3—lung cancer	4.93e-06	4.22e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ALB—lung cancer	4.93e-06	4.21e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ABCB1—lung cancer	4.9e-06	4.19e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CA—lung cancer	4.89e-06	4.19e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—UGT1A1—lung cancer	4.89e-06	4.18e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CD—lung cancer	4.84e-06	4.14e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TYMS—lung cancer	4.81e-06	4.12e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ALB—lung cancer	4.77e-06	4.08e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTM1—lung cancer	4.76e-06	4.07e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GNG11—lung cancer	4.72e-06	4.03e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—STK11—lung cancer	4.62e-06	3.95e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—STK11—lung cancer	4.58e-06	3.92e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP1A1—lung cancer	4.51e-06	3.86e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOA1—lung cancer	4.49e-06	3.84e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALDOA—lung cancer	4.49e-06	3.84e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ERCC2—lung cancer	4.47e-06	3.83e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTEN—lung cancer	4.47e-06	3.82e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—KRAS—lung cancer	4.43e-06	3.79e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NCOA3—lung cancer	4.36e-06	3.73e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CB—lung cancer	4.35e-06	3.72e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—lung cancer	4.31e-06	3.69e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.3e-06	3.68e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTP1—lung cancer	4.28e-06	3.66e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—EP300—lung cancer	4.26e-06	3.65e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ADCY1—lung cancer	4.24e-06	3.63e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ABCG2—lung cancer	4.24e-06	3.63e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTP1—lung cancer	4.24e-06	3.63e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CB—lung cancer	4.22e-06	3.61e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AKT1—lung cancer	4.18e-06	3.58e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—lung cancer	4.18e-06	3.57e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CAT—lung cancer	4.16e-06	3.56e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ENO2—lung cancer	4.16e-06	3.56e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HPGDS—lung cancer	4.16e-06	3.56e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.13e-06	3.53e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CAT—lung cancer	4.12e-06	3.53e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CG—lung cancer	4.1e-06	3.51e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.1e-06	3.51e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CA—lung cancer	4.07e-06	3.48e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AKT1—lung cancer	4.06e-06	3.47e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ABCB1—lung cancer	4.05e-06	3.46e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTT1—lung cancer	4.03e-06	3.45e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ABCB1—lung cancer	4.01e-06	3.43e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AKT1—lung cancer	4e-06	3.42e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP2A6—lung cancer	3.99e-06	3.41e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GCLC—lung cancer	3.99e-06	3.41e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TYMS—lung cancer	3.98e-06	3.4e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TYMS—lung cancer	3.94e-06	3.37e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—lung cancer	3.94e-06	3.37e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTM1—lung cancer	3.93e-06	3.36e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—POMC—lung cancer	3.91e-06	3.34e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTM1—lung cancer	3.9e-06	3.33e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOA1—lung cancer	3.87e-06	3.31e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—AKT1—lung cancer	3.85e-06	3.3e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CREBBP—lung cancer	3.8e-06	3.25e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ENO1—lung cancer	3.78e-06	3.23e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—HRAS—lung cancer	3.77e-06	3.22e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTEN—lung cancer	3.76e-06	3.22e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP1A1—lung cancer	3.73e-06	3.19e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.71e-06	3.17e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ERCC2—lung cancer	3.69e-06	3.16e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP1A1—lung cancer	3.69e-06	3.16e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CA—lung cancer	3.67e-06	3.14e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ERCC2—lung cancer	3.66e-06	3.13e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTEN—lung cancer	3.64e-06	3.12e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CD—lung cancer	3.61e-06	3.09e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—EP300—lung cancer	3.58e-06	3.07e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ALB—lung cancer	3.56e-06	3.05e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CG—lung cancer	3.53e-06	3.02e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—EP300—lung cancer	3.47e-06	2.97e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP2E1—lung cancer	3.39e-06	2.9e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—POMC—lung cancer	3.36e-06	2.88e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NQO1—lung cancer	3.35e-06	2.87e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT1—lung cancer	3.33e-06	2.85e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CREBBP—lung cancer	3.28e-06	2.8e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOA1—lung cancer	3.2e-06	2.73e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOA1—lung cancer	3.17e-06	2.71e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CA—lung cancer	3.15e-06	2.7e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CB—lung cancer	3.14e-06	2.69e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—lung cancer	3.12e-06	2.66e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CD—lung cancer	3.11e-06	2.66e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.03e-06	2.6e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—STK11—lung cancer	3.02e-06	2.58e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKT1—lung cancer	3e-06	2.56e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CG—lung cancer	2.92e-06	2.5e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CG—lung cancer	2.89e-06	2.47e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTP1—lung cancer	2.8e-06	2.39e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—POMC—lung cancer	2.78e-06	2.38e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—POMC—lung cancer	2.75e-06	2.36e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CAT—lung cancer	2.72e-06	2.33e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTEN—lung cancer	2.72e-06	2.32e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CB—lung cancer	2.71e-06	2.32e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CREBBP—lung cancer	2.71e-06	2.31e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—lung cancer	2.68e-06	2.3e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CREBBP—lung cancer	2.68e-06	2.29e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CA—lung cancer	2.65e-06	2.27e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ABCB1—lung cancer	2.65e-06	2.26e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TYMS—lung cancer	2.6e-06	2.22e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—EP300—lung cancer	2.59e-06	2.22e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKT1—lung cancer	2.58e-06	2.2e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CA—lung cancer	2.57e-06	2.2e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTM1—lung cancer	2.57e-06	2.2e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CD—lung cancer	2.56e-06	2.19e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CD—lung cancer	2.54e-06	2.18e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALB—lung cancer	2.53e-06	2.17e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALB—lung cancer	2.51e-06	2.15e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP1A1—lung cancer	2.44e-06	2.08e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ERCC2—lung cancer	2.42e-06	2.07e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTEN—lung cancer	2.34e-06	2e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CB—lung cancer	2.24e-06	1.91e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—EP300—lung cancer	2.23e-06	1.91e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CB—lung cancer	2.22e-06	1.9e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—lung cancer	2.22e-06	1.89e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—lung cancer	2.2e-06	1.88e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKT1—lung cancer	2.17e-06	1.85e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKT1—lung cancer	2.1e-06	1.8e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOA1—lung cancer	2.09e-06	1.79e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTEN—lung cancer	1.93e-06	1.65e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CA—lung cancer	1.92e-06	1.64e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTEN—lung cancer	1.92e-06	1.64e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CG—lung cancer	1.91e-06	1.63e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—EP300—lung cancer	1.84e-06	1.58e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—EP300—lung cancer	1.83e-06	1.56e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—POMC—lung cancer	1.82e-06	1.55e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CREBBP—lung cancer	1.77e-06	1.51e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CD—lung cancer	1.68e-06	1.43e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALB—lung cancer	1.66e-06	1.42e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CA—lung cancer	1.65e-06	1.41e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKT1—lung cancer	1.57e-06	1.34e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CB—lung cancer	1.46e-06	1.25e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—lung cancer	1.45e-06	1.24e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CA—lung cancer	1.36e-06	1.17e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CA—lung cancer	1.35e-06	1.16e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKT1—lung cancer	1.35e-06	1.15e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTEN—lung cancer	1.26e-06	1.08e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—EP300—lung cancer	1.2e-06	1.03e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKT1—lung cancer	1.11e-06	9.52e-06	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKT1—lung cancer	1.1e-06	9.44e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CA—lung cancer	8.91e-07	7.62e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKT1—lung cancer	7.28e-07	6.23e-06	CbGpPWpGaD
